Loading…

Peptidomic analysis of type 1 diabetes associated HLA‐DQ molecules and the impact of HLA‐DM on peptide repertoire editing

HLA‐DM and class II associated invariant chain (Ii) are key cofactors in the MHC class II (MHCII) antigen processing pathway. We used tandem mass spectrometry sequencing to directly interrogate the global impact of DM and Ii on the repertoire of MHCII‐bound peptides in human embryonic kidney 293T ce...

Full description

Saved in:
Bibliographic Details
Published in:European journal of immunology 2017-02, Vol.47 (2), p.314-326
Main Authors: Zhou, Zemin, Reyes‐Vargas, Eduardo, Escobar, Hernando, Chang, Kuan Y., Barker, Adam P., Rockwood, Alan L., Delgado, Julio C., He, Xiao, Jensen, Peter E.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c4364-f0f3708673aa3de05ae1d83633599a1a2b30604a17afdc0d56fb47bc991063133
cites cdi_FETCH-LOGICAL-c4364-f0f3708673aa3de05ae1d83633599a1a2b30604a17afdc0d56fb47bc991063133
container_end_page 326
container_issue 2
container_start_page 314
container_title European journal of immunology
container_volume 47
creator Zhou, Zemin
Reyes‐Vargas, Eduardo
Escobar, Hernando
Chang, Kuan Y.
Barker, Adam P.
Rockwood, Alan L.
Delgado, Julio C.
He, Xiao
Jensen, Peter E.
description HLA‐DM and class II associated invariant chain (Ii) are key cofactors in the MHC class II (MHCII) antigen processing pathway. We used tandem mass spectrometry sequencing to directly interrogate the global impact of DM and Ii on the repertoire of MHCII‐bound peptides in human embryonic kidney 293T cells expressing HLA‐DQ molecules in the absence or presence of these cofactors. We found that Ii and DM have a major impact on the repertoire of peptides presented by DQ1 and DQ6, with the caveat that this technology is not quantitative. The peptide repertoires of type 1 diabetes (T1D) associated DQ8, DQ2, and DQ8/2 are altered to a lesser degree by DM expression, and these molecules share overlapping features in their peptide binding motifs that are distinct from control DQ1 and DQ6 molecules. Peptides were categorized into DM‐resistant, DM‐dependent, or DM‐sensitive groups based on the mass spectrometry data, and representative peptides were tested in competitive binding assays and peptide dissociation rate experiments with soluble DQ6. Our data support the conclusion that high intrinsic stability of DQ‐peptide complexes is necessary but not sufficient to confer resistance to DM editing, and provide candidate parameters that may be useful in predicting the sensitivity of T‐cell epitopes to DM editing. DM editing favors the enrichment of stable DQ–peptide complexes. Unstable complexes are universally sensitive to DM. DM‐resistant complexes are stable, but a subset of stable complexes is sensitive to DM. The peptide repertoires of type 1 diabetes associated DQ molecules are impacted less by DM than control DQ molecules.
doi_str_mv 10.1002/eji.201646656
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1872818943</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1895090565</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4364-f0f3708673aa3de05ae1d83633599a1a2b30604a17afdc0d56fb47bc991063133</originalsourceid><addsrcrecordid>eNqN0cFu1DAQBmALgehSOHJFlrhwSZmJHcc-VqWlRYsACc6RE0_AqyQOsSO0B6Q-As_Ik5CwSw8cEKc5-PM_0vyMPUU4Q4D8Je38WQ6opFKFusc2WOSYSZR4n20AUGa50XDCHsW4AwCjCvOQneSlVqhBb9j39zQm70LvG24H2-2jjzy0PO1H4sidtzUlitzGGBpvEzl-vT3_efvj1Qfeh46auVtfB8fTF-K-H22T1v9H9JaHgY-_VxCfaKQpBT8RJ-eTHz4_Zg9a20V6cpyn7NPV5ceL62z77vXNxfk2a6RQMmuhFSVoVQprhSMoLKHTQglRGGPR5rUABdJiaVvXgCtUW8uyboxBUAKFOGUvDrnjFL7OFFPV-9hQ19mBwhwr1GWuURv5P1Qul0OdFwt9_hfdhXlajrgqU4CBQq0qO6hmCjFO1Fbj5Hs77SuEaq2wWiqs7ipc_LNj6lz35O70n84WkB_AN9_R_t9p1eWbG6FRil8A0KYr</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1895090565</pqid></control><display><type>article</type><title>Peptidomic analysis of type 1 diabetes associated HLA‐DQ molecules and the impact of HLA‐DM on peptide repertoire editing</title><source>Wiley:Jisc Collections:Wiley Read and Publish Open Access 2024-2025 (reading list)</source><creator>Zhou, Zemin ; Reyes‐Vargas, Eduardo ; Escobar, Hernando ; Chang, Kuan Y. ; Barker, Adam P. ; Rockwood, Alan L. ; Delgado, Julio C. ; He, Xiao ; Jensen, Peter E.</creator><creatorcontrib>Zhou, Zemin ; Reyes‐Vargas, Eduardo ; Escobar, Hernando ; Chang, Kuan Y. ; Barker, Adam P. ; Rockwood, Alan L. ; Delgado, Julio C. ; He, Xiao ; Jensen, Peter E.</creatorcontrib><description>HLA‐DM and class II associated invariant chain (Ii) are key cofactors in the MHC class II (MHCII) antigen processing pathway. We used tandem mass spectrometry sequencing to directly interrogate the global impact of DM and Ii on the repertoire of MHCII‐bound peptides in human embryonic kidney 293T cells expressing HLA‐DQ molecules in the absence or presence of these cofactors. We found that Ii and DM have a major impact on the repertoire of peptides presented by DQ1 and DQ6, with the caveat that this technology is not quantitative. The peptide repertoires of type 1 diabetes (T1D) associated DQ8, DQ2, and DQ8/2 are altered to a lesser degree by DM expression, and these molecules share overlapping features in their peptide binding motifs that are distinct from control DQ1 and DQ6 molecules. Peptides were categorized into DM‐resistant, DM‐dependent, or DM‐sensitive groups based on the mass spectrometry data, and representative peptides were tested in competitive binding assays and peptide dissociation rate experiments with soluble DQ6. Our data support the conclusion that high intrinsic stability of DQ‐peptide complexes is necessary but not sufficient to confer resistance to DM editing, and provide candidate parameters that may be useful in predicting the sensitivity of T‐cell epitopes to DM editing. DM editing favors the enrichment of stable DQ–peptide complexes. Unstable complexes are universally sensitive to DM. DM‐resistant complexes are stable, but a subset of stable complexes is sensitive to DM. The peptide repertoires of type 1 diabetes associated DQ molecules are impacted less by DM than control DQ molecules.</description><identifier>ISSN: 0014-2980</identifier><identifier>EISSN: 1521-4141</identifier><identifier>DOI: 10.1002/eji.201646656</identifier><identifier>PMID: 27861808</identifier><language>eng</language><publisher>Germany: Wiley Subscription Services, Inc</publisher><subject>Amino Acid Motifs - genetics ; Antigen Presentation ; Antigen processing ; Antigens - metabolism ; Antigens, Differentiation, B-Lymphocyte - metabolism ; Assaying ; Cofactors ; Computer Simulation ; Diabetes ; Diabetes mellitus ; Diabetes Mellitus, Type 1 - immunology ; Editing ; Epitopes ; Epitopes, T-Lymphocyte - genetics ; HEK293 Cells ; Histocompatibility antigen HLA ; Histocompatibility Antigens Class II - metabolism ; HLA-D Antigens - metabolism ; HLA-DQ Antigens - metabolism ; HLA‐DM ; Humans ; Invariant chain ; Lymphocytes T ; Major histocompatibility complex ; Mass spectrometry ; Mass spectroscopy ; MHC ; Peptides ; Peptides - metabolism ; Peptidomic analysis ; Protein Binding ; Protein Stability ; Scientific imaging ; Tandem Mass Spectrometry</subject><ispartof>European journal of immunology, 2017-02, Vol.47 (2), p.314-326</ispartof><rights>2016 WILEY‐VCH Verlag GmbH &amp; Co. KGaA, Weinheim</rights><rights>2016 WILEY-VCH Verlag GmbH &amp; Co. KGaA, Weinheim.</rights><rights>2017 WILEY-VCH Verlag GmbH &amp; Co. KGaA, Weinheim</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4364-f0f3708673aa3de05ae1d83633599a1a2b30604a17afdc0d56fb47bc991063133</citedby><cites>FETCH-LOGICAL-c4364-f0f3708673aa3de05ae1d83633599a1a2b30604a17afdc0d56fb47bc991063133</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27861808$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Zhou, Zemin</creatorcontrib><creatorcontrib>Reyes‐Vargas, Eduardo</creatorcontrib><creatorcontrib>Escobar, Hernando</creatorcontrib><creatorcontrib>Chang, Kuan Y.</creatorcontrib><creatorcontrib>Barker, Adam P.</creatorcontrib><creatorcontrib>Rockwood, Alan L.</creatorcontrib><creatorcontrib>Delgado, Julio C.</creatorcontrib><creatorcontrib>He, Xiao</creatorcontrib><creatorcontrib>Jensen, Peter E.</creatorcontrib><title>Peptidomic analysis of type 1 diabetes associated HLA‐DQ molecules and the impact of HLA‐DM on peptide repertoire editing</title><title>European journal of immunology</title><addtitle>Eur J Immunol</addtitle><description>HLA‐DM and class II associated invariant chain (Ii) are key cofactors in the MHC class II (MHCII) antigen processing pathway. We used tandem mass spectrometry sequencing to directly interrogate the global impact of DM and Ii on the repertoire of MHCII‐bound peptides in human embryonic kidney 293T cells expressing HLA‐DQ molecules in the absence or presence of these cofactors. We found that Ii and DM have a major impact on the repertoire of peptides presented by DQ1 and DQ6, with the caveat that this technology is not quantitative. The peptide repertoires of type 1 diabetes (T1D) associated DQ8, DQ2, and DQ8/2 are altered to a lesser degree by DM expression, and these molecules share overlapping features in their peptide binding motifs that are distinct from control DQ1 and DQ6 molecules. Peptides were categorized into DM‐resistant, DM‐dependent, or DM‐sensitive groups based on the mass spectrometry data, and representative peptides were tested in competitive binding assays and peptide dissociation rate experiments with soluble DQ6. Our data support the conclusion that high intrinsic stability of DQ‐peptide complexes is necessary but not sufficient to confer resistance to DM editing, and provide candidate parameters that may be useful in predicting the sensitivity of T‐cell epitopes to DM editing. DM editing favors the enrichment of stable DQ–peptide complexes. Unstable complexes are universally sensitive to DM. DM‐resistant complexes are stable, but a subset of stable complexes is sensitive to DM. The peptide repertoires of type 1 diabetes associated DQ molecules are impacted less by DM than control DQ molecules.</description><subject>Amino Acid Motifs - genetics</subject><subject>Antigen Presentation</subject><subject>Antigen processing</subject><subject>Antigens - metabolism</subject><subject>Antigens, Differentiation, B-Lymphocyte - metabolism</subject><subject>Assaying</subject><subject>Cofactors</subject><subject>Computer Simulation</subject><subject>Diabetes</subject><subject>Diabetes mellitus</subject><subject>Diabetes Mellitus, Type 1 - immunology</subject><subject>Editing</subject><subject>Epitopes</subject><subject>Epitopes, T-Lymphocyte - genetics</subject><subject>HEK293 Cells</subject><subject>Histocompatibility antigen HLA</subject><subject>Histocompatibility Antigens Class II - metabolism</subject><subject>HLA-D Antigens - metabolism</subject><subject>HLA-DQ Antigens - metabolism</subject><subject>HLA‐DM</subject><subject>Humans</subject><subject>Invariant chain</subject><subject>Lymphocytes T</subject><subject>Major histocompatibility complex</subject><subject>Mass spectrometry</subject><subject>Mass spectroscopy</subject><subject>MHC</subject><subject>Peptides</subject><subject>Peptides - metabolism</subject><subject>Peptidomic analysis</subject><subject>Protein Binding</subject><subject>Protein Stability</subject><subject>Scientific imaging</subject><subject>Tandem Mass Spectrometry</subject><issn>0014-2980</issn><issn>1521-4141</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNqN0cFu1DAQBmALgehSOHJFlrhwSZmJHcc-VqWlRYsACc6RE0_AqyQOsSO0B6Q-As_Ik5CwSw8cEKc5-PM_0vyMPUU4Q4D8Je38WQ6opFKFusc2WOSYSZR4n20AUGa50XDCHsW4AwCjCvOQneSlVqhBb9j39zQm70LvG24H2-2jjzy0PO1H4sidtzUlitzGGBpvEzl-vT3_efvj1Qfeh46auVtfB8fTF-K-H22T1v9H9JaHgY-_VxCfaKQpBT8RJ-eTHz4_Zg9a20V6cpyn7NPV5ceL62z77vXNxfk2a6RQMmuhFSVoVQprhSMoLKHTQglRGGPR5rUABdJiaVvXgCtUW8uyboxBUAKFOGUvDrnjFL7OFFPV-9hQ19mBwhwr1GWuURv5P1Qul0OdFwt9_hfdhXlajrgqU4CBQq0qO6hmCjFO1Fbj5Hs77SuEaq2wWiqs7ipc_LNj6lz35O70n84WkB_AN9_R_t9p1eWbG6FRil8A0KYr</recordid><startdate>201702</startdate><enddate>201702</enddate><creator>Zhou, Zemin</creator><creator>Reyes‐Vargas, Eduardo</creator><creator>Escobar, Hernando</creator><creator>Chang, Kuan Y.</creator><creator>Barker, Adam P.</creator><creator>Rockwood, Alan L.</creator><creator>Delgado, Julio C.</creator><creator>He, Xiao</creator><creator>Jensen, Peter E.</creator><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7T5</scope><scope>7TK</scope><scope>7TM</scope><scope>8FD</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope></search><sort><creationdate>201702</creationdate><title>Peptidomic analysis of type 1 diabetes associated HLA‐DQ molecules and the impact of HLA‐DM on peptide repertoire editing</title><author>Zhou, Zemin ; Reyes‐Vargas, Eduardo ; Escobar, Hernando ; Chang, Kuan Y. ; Barker, Adam P. ; Rockwood, Alan L. ; Delgado, Julio C. ; He, Xiao ; Jensen, Peter E.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4364-f0f3708673aa3de05ae1d83633599a1a2b30604a17afdc0d56fb47bc991063133</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Amino Acid Motifs - genetics</topic><topic>Antigen Presentation</topic><topic>Antigen processing</topic><topic>Antigens - metabolism</topic><topic>Antigens, Differentiation, B-Lymphocyte - metabolism</topic><topic>Assaying</topic><topic>Cofactors</topic><topic>Computer Simulation</topic><topic>Diabetes</topic><topic>Diabetes mellitus</topic><topic>Diabetes Mellitus, Type 1 - immunology</topic><topic>Editing</topic><topic>Epitopes</topic><topic>Epitopes, T-Lymphocyte - genetics</topic><topic>HEK293 Cells</topic><topic>Histocompatibility antigen HLA</topic><topic>Histocompatibility Antigens Class II - metabolism</topic><topic>HLA-D Antigens - metabolism</topic><topic>HLA-DQ Antigens - metabolism</topic><topic>HLA‐DM</topic><topic>Humans</topic><topic>Invariant chain</topic><topic>Lymphocytes T</topic><topic>Major histocompatibility complex</topic><topic>Mass spectrometry</topic><topic>Mass spectroscopy</topic><topic>MHC</topic><topic>Peptides</topic><topic>Peptides - metabolism</topic><topic>Peptidomic analysis</topic><topic>Protein Binding</topic><topic>Protein Stability</topic><topic>Scientific imaging</topic><topic>Tandem Mass Spectrometry</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zhou, Zemin</creatorcontrib><creatorcontrib>Reyes‐Vargas, Eduardo</creatorcontrib><creatorcontrib>Escobar, Hernando</creatorcontrib><creatorcontrib>Chang, Kuan Y.</creatorcontrib><creatorcontrib>Barker, Adam P.</creatorcontrib><creatorcontrib>Rockwood, Alan L.</creatorcontrib><creatorcontrib>Delgado, Julio C.</creatorcontrib><creatorcontrib>He, Xiao</creatorcontrib><creatorcontrib>Jensen, Peter E.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zhou, Zemin</au><au>Reyes‐Vargas, Eduardo</au><au>Escobar, Hernando</au><au>Chang, Kuan Y.</au><au>Barker, Adam P.</au><au>Rockwood, Alan L.</au><au>Delgado, Julio C.</au><au>He, Xiao</au><au>Jensen, Peter E.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Peptidomic analysis of type 1 diabetes associated HLA‐DQ molecules and the impact of HLA‐DM on peptide repertoire editing</atitle><jtitle>European journal of immunology</jtitle><addtitle>Eur J Immunol</addtitle><date>2017-02</date><risdate>2017</risdate><volume>47</volume><issue>2</issue><spage>314</spage><epage>326</epage><pages>314-326</pages><issn>0014-2980</issn><eissn>1521-4141</eissn><abstract>HLA‐DM and class II associated invariant chain (Ii) are key cofactors in the MHC class II (MHCII) antigen processing pathway. We used tandem mass spectrometry sequencing to directly interrogate the global impact of DM and Ii on the repertoire of MHCII‐bound peptides in human embryonic kidney 293T cells expressing HLA‐DQ molecules in the absence or presence of these cofactors. We found that Ii and DM have a major impact on the repertoire of peptides presented by DQ1 and DQ6, with the caveat that this technology is not quantitative. The peptide repertoires of type 1 diabetes (T1D) associated DQ8, DQ2, and DQ8/2 are altered to a lesser degree by DM expression, and these molecules share overlapping features in their peptide binding motifs that are distinct from control DQ1 and DQ6 molecules. Peptides were categorized into DM‐resistant, DM‐dependent, or DM‐sensitive groups based on the mass spectrometry data, and representative peptides were tested in competitive binding assays and peptide dissociation rate experiments with soluble DQ6. Our data support the conclusion that high intrinsic stability of DQ‐peptide complexes is necessary but not sufficient to confer resistance to DM editing, and provide candidate parameters that may be useful in predicting the sensitivity of T‐cell epitopes to DM editing. DM editing favors the enrichment of stable DQ–peptide complexes. Unstable complexes are universally sensitive to DM. DM‐resistant complexes are stable, but a subset of stable complexes is sensitive to DM. The peptide repertoires of type 1 diabetes associated DQ molecules are impacted less by DM than control DQ molecules.</abstract><cop>Germany</cop><pub>Wiley Subscription Services, Inc</pub><pmid>27861808</pmid><doi>10.1002/eji.201646656</doi><tpages>13</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0014-2980
ispartof European journal of immunology, 2017-02, Vol.47 (2), p.314-326
issn 0014-2980
1521-4141
language eng
recordid cdi_proquest_miscellaneous_1872818943
source Wiley:Jisc Collections:Wiley Read and Publish Open Access 2024-2025 (reading list)
subjects Amino Acid Motifs - genetics
Antigen Presentation
Antigen processing
Antigens - metabolism
Antigens, Differentiation, B-Lymphocyte - metabolism
Assaying
Cofactors
Computer Simulation
Diabetes
Diabetes mellitus
Diabetes Mellitus, Type 1 - immunology
Editing
Epitopes
Epitopes, T-Lymphocyte - genetics
HEK293 Cells
Histocompatibility antigen HLA
Histocompatibility Antigens Class II - metabolism
HLA-D Antigens - metabolism
HLA-DQ Antigens - metabolism
HLA‐DM
Humans
Invariant chain
Lymphocytes T
Major histocompatibility complex
Mass spectrometry
Mass spectroscopy
MHC
Peptides
Peptides - metabolism
Peptidomic analysis
Protein Binding
Protein Stability
Scientific imaging
Tandem Mass Spectrometry
title Peptidomic analysis of type 1 diabetes associated HLA‐DQ molecules and the impact of HLA‐DM on peptide repertoire editing
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-31T23%3A51%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Peptidomic%20analysis%20of%20type%201%20diabetes%20associated%20HLA%E2%80%90DQ%20molecules%20and%20the%20impact%20of%20HLA%E2%80%90DM%20on%20peptide%20repertoire%20editing&rft.jtitle=European%20journal%20of%20immunology&rft.au=Zhou,%20Zemin&rft.date=2017-02&rft.volume=47&rft.issue=2&rft.spage=314&rft.epage=326&rft.pages=314-326&rft.issn=0014-2980&rft.eissn=1521-4141&rft_id=info:doi/10.1002/eji.201646656&rft_dat=%3Cproquest_cross%3E1895090565%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4364-f0f3708673aa3de05ae1d83633599a1a2b30604a17afdc0d56fb47bc991063133%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1895090565&rft_id=info:pmid/27861808&rfr_iscdi=true